Fact check · Version 1 · Sources checked
“Thymosin alpha-1 is FDA-approved in the United States.”
The Peptide Field explains research. Its pages are not independently medically reviewed, and they do not diagnose, prescribe, or recommend treatment.
Misleading
This statement leaves out a limit that changes its meaning.
FDA says no approved U.S. drug contains thymosin alpha-1 free base or its acetate salt. Foreign product status does not create U.S. approval.
- What this answer is based on
- This answer uses an official regulator record or a specific product label.
- Limits of this answer
- United States regulatory status as reviewed August 30, 2026. These limits show which substance, product, people, use, place, and time the answer covers. A different product or situation can have a different answer.
- Topic
- Whether a specific product has an approval or another official status.
Sources for this fact check
Show 3 sources
01FDA evaluation of thymosin alpha-1 for pharmacy compoundingU.S. Food and Drug Administration · FDA review · 202402FDA list of substances that may present compounding safety risksU.S. Food and Drug Administration · Regulatory · 202603FDA drug approvals and databasesU.S. Food and Drug Administration · Regulatory · 2026
- Sources checked by
- Site editor · Editorial review